0001782250-20-000001.txt : 20200722 0001782250-20-000001.hdr.sgml : 20200722 20200722110541 ACCESSION NUMBER: 0001782250-20-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200722 DATE AS OF CHANGE: 20200722 EFFECTIVENESS DATE: 20200722 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lucy Therapeutics, Inc. CENTRAL INDEX KEY: 0001782250 IRS NUMBER: 822363951 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-344266 FILM NUMBER: 201040763 BUSINESS ADDRESS: STREET 1: 501 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-249-4812 MAIL ADDRESS: STREET 1: 501 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02139 D/A 1 primary_doc.xml X0708 D/A LIVE 0001782250 Lucy Therapeutics, Inc. 501 MASSACHUSETTS AVENUE CAMBRIDGE MA MASSACHUSETTS 02139 617-249-4812 DELAWARE None None Corporation true 2017 Amy Ripka 501 Massachusetts Avenue Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Ann DeWitt 501 Massachusetts Avenue Cambridge MA MASSACHUSETTS 02139 Director John Ripple 501 Massachusetts Avenue Cambridge MA MASSACHUSETTS 02139 Director Pharmaceuticals Decline to Disclose 06b true 0001782250-19-000003 2019-06-28 false true false 0 4509472 3019999 1489473 false 4 0 0 0 false Lucy Therapeutics, Inc. /s/ Amy Ripka Amy Ripka President 2020-07-22